In addition to cells of the bone microenvironment, myeloma cells are also known to express OPN [50,51], and it cannot be excluded that the increase in OPN reflects the elevated tumour burden observed following metformin pre-treatment. The gene discussed is SPP1; the disease is neoplasm.